Skip to main content
. 2022 Aug 8;2022:8612933. doi: 10.1155/2022/8612933

Table 4.

Antibiotic susceptibility profile of multidrug E. coli and K. pneumoniae.

Antibiotics E. coli (n = 44)
(95% CI)
K. pneumoniae (n = 34)
(95% CI)
Resistant Sensitive Resistant Sensitive
AMX 100% (44) 0 100%(34) 0
AMC 97.7% (43) [87.99%-99.92%] 2.3% (1) 100%(34) 0
TIC 100% (44) 0 100%(34) 0
CF 100% (44) 0 100%(34) 0
FOX 9.1% (4) [2.53%-21.66%] 90.9% (40) [78.33%-97.46%] 41.2% (14) [24.64%-59.30%] 58.8% (20) [40.69%-75.35%]
CFM 97.7% (43) [87.99%-99.92%] 2.3% (1) 97.1% (33)[84.67%-99.92%] 2.9% (1)
CAZ 97.7% (43) [87.99%-99.92%] 2.3% (1) 94.1% (32) [80.32%-99.27%] 5.9% (2) [0.72%-1.96%]
CTX 97.7% (43) [87.99%-99.92%] 2.3% (1) 97.1% (33) [84.67%-99.92%] 2.9% (1)
IMP 2.3% (1) 97.7%(43) [87.99%-99.92%] 29.4% (10) [15.09%-47.47%] 70.6% (24) [52.52%-84.90%]
AN 25% (11) [13.19%-40.33%] 75% (33) [59.66%-86.80%] 17.6% (6) [6.76%-34.53%] 82.4% (28) [65.46%-93.23%]
GM 45.5% (20) [30.39%-61.15%] 54.5% (24)[38.84%-69.60%] 61.8% (21) [43.56%-77.83%] 38.2% (13) [22.16%-56.43%]
NET 59.1% (26) [43.24%-73.66%] 40.9% (18)[26.33%-56.75%] 52.9% (18) [35.12%-70.22%] 47.1% (16) [29.77%-64.87%]
NN 63.6% (28) [47.77%-77.59%] 36.4% (16)[22.40%-52.2%] 61.8% (21) [43.56%-77.83%] 38.2% (13) [22.16%-56.43%]
NA 88.6% (39) [75.44%-96.20%] 11.4% (5)[11.36%-37.94%] 85.3% (29) [68.94%-95.04%] 14.7% (5) [4.95%-31.05%]
OFX 95.5% (42) [84.52%-99.44%] 4.5% (2)[0.5%-1.54%] 85.3% (29) [68.94%-95.04%] 14.7% (5) [4.95%-31.05%]
CIP 93.2% (41) [81.34%-98.57%] 6.8% (3)[1.42%-18.65%] 82.4% (28) [65.46%-93.23%] 17.6% (6) [6.76%-34.53%]
FFL 9.1% (4) [2.53%-21.66%] 90.9% (40)[78.33%-97.46%] 50% (17) [32.42%-67.57%] 50% (17) [32.42%-67.57%]
SXT 68.2% (30) [52.42%-81.39%] 31.8% (14)[18.60%-47.57%] 67.6% (23)[49.47%-82.61%] 32.4% (11) [17.38%-50.52%]
CL 0 100% (44) 0 100%(34)

AMX: amoxicillin; AMC: amoxicillin + clavulanic acid; TIC; ticarcillin; CF: cephalexin; CFM: cefixime; FOX: cefoxitin; CTX: cefotaxime; CAZ: ceftazidime; IMP: imipenem; NA: nalidixic acid; OFX: ofloxacin; CIP: ciprofloxacin; AN: amikacin, GM: gentamycin; NET: netilmicin; NN: tobramycin; FFL: fosfomycine; SXT: trimethoprim + sulfamide; CL: colistin.